nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.0503	0.119	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.0441	0.104	CbGpPWpGaD
Adenosine—Apprehension—Cisplatin—bone cancer	0.041	0.0742	CcSEcCtD
Adenosine—ADK—Nucleotide metabolism—NT5C3A—bone cancer	0.0334	0.0787	CbGpPWpGaD
Adenosine—ADA—Nucleotide metabolism—NT5C3A—bone cancer	0.0227	0.0535	CbGpPWpGaD
Adenosine—Coronary artery disease—Cisplatin—bone cancer	0.0199	0.036	CcSEcCtD
Adenosine—Glucosamine—MMP9—bone cancer	0.0194	0.853	CrCbGaD
Adenosine—Electrocardiogram ST segment depression—Epirubicin—bone cancer	0.0178	0.0322	CcSEcCtD
Adenosine—Electrocardiogram ST segment depression—Doxorubicin—bone cancer	0.0165	0.0298	CcSEcCtD
Adenosine—Taste metallic—Methotrexate—bone cancer	0.0136	0.0245	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0119	0.0281	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—WT1—bone cancer	0.011	0.0259	CbGpPWpGaD
Adenosine—Supraventricular extrasystoles—Epirubicin—bone cancer	0.0108	0.0196	CcSEcCtD
Adenosine—Supraventricular extrasystoles—Doxorubicin—bone cancer	0.01	0.0181	CcSEcCtD
Adenosine—Sinus tachycardia—Epirubicin—bone cancer	0.01	0.0181	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00979	0.0231	CbGpPWpGaD
Adenosine—Sinus tachycardia—Doxorubicin—bone cancer	0.00928	0.0168	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00888	0.0209	CbGpPWpGaD
Adenosine—Pain—Carboplatin—bone cancer	0.00819	0.0148	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00685	0.0162	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Other—GRM1—bone cancer	0.00679	0.016	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—BRCA2—bone cancer	0.00646	0.0152	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—MOGS—bone cancer	0.00633	0.0149	CbGpPWpGaD
Adenosine—Nasal congestion—Cisplatin—bone cancer	0.00627	0.0113	CcSEcCtD
Adenosine—Burning sensation—Methotrexate—bone cancer	0.00622	0.0112	CcSEcCtD
Adenosine—Hyperventilation—Epirubicin—bone cancer	0.00587	0.0106	CcSEcCtD
Adenosine—Cerebrovascular accident—Cisplatin—bone cancer	0.00583	0.0105	CcSEcCtD
Adenosine—Burning sensation—Epirubicin—bone cancer	0.00582	0.0105	CcSEcCtD
Adenosine—Ventricular arrhythmia—Epirubicin—bone cancer	0.00546	0.00987	CcSEcCtD
Adenosine—Hyperventilation—Doxorubicin—bone cancer	0.00543	0.00982	CcSEcCtD
Adenosine—Burning sensation—Doxorubicin—bone cancer	0.00538	0.00973	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.00538	0.0127	CbGpPWpGaD
Adenosine—Scotoma—Epirubicin—bone cancer	0.00532	0.00962	CcSEcCtD
Adenosine—Apnoea—Methotrexate—bone cancer	0.00509	0.00921	CcSEcCtD
Adenosine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00505	0.00913	CcSEcCtD
Adenosine—Scotoma—Doxorubicin—bone cancer	0.00492	0.0089	CcSEcCtD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—MDM2—bone cancer	0.00482	0.0114	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Other—SMO—bone cancer	0.00478	0.0113	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—GRM4—bone cancer	0.00475	0.0112	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—RGS1—bone cancer	0.00475	0.0112	CbGpPWpGaD
Adenosine—Abdominal discomfort—Cisplatin—bone cancer	0.00473	0.00855	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00468	0.011	CbGpPWpGaD
Adenosine—Ventricular extrasystoles—Epirubicin—bone cancer	0.00447	0.00809	CcSEcCtD
Adenosine—Respiratory failure—Methotrexate—bone cancer	0.0044	0.00795	CcSEcCtD
Adenosine—Acute coronary syndrome—Cisplatin—bone cancer	0.00434	0.00784	CcSEcCtD
Adenosine—Myocardial infarction—Cisplatin—bone cancer	0.00432	0.0078	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—KIT—bone cancer	0.00429	0.0101	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—RB1—bone cancer	0.00417	0.00983	CbGpPWpGaD
Adenosine—Atrioventricular block—Epirubicin—bone cancer	0.00417	0.00753	CcSEcCtD
Adenosine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00414	0.00748	CcSEcCtD
Adenosine—Ventricular tachycardia—Epirubicin—bone cancer	0.00404	0.0073	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—GNA11—bone cancer	0.00404	0.00953	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00404	0.00953	CbGpPWpGaD
Adenosine—Bradycardia—Cisplatin—bone cancer	0.00402	0.00727	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—EZH2—bone cancer	0.00402	0.00949	CbGpPWpGaD
Adenosine—Injection site reaction—Epirubicin—bone cancer	0.00402	0.00726	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—bone cancer	0.00385	0.00697	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—KIT—bone cancer	0.00376	0.00886	CbGpPWpGaD
Adenosine—Ventricular tachycardia—Doxorubicin—bone cancer	0.00374	0.00676	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—bone cancer	0.00372	0.00672	CcSEcCtD
Adenosine—Tinnitus—Cisplatin—bone cancer	0.00368	0.00666	CcSEcCtD
Adenosine—Cardiac disorder—Cisplatin—bone cancer	0.00367	0.00663	CcSEcCtD
Adenosine—Flushing—Cisplatin—bone cancer	0.00367	0.00663	CcSEcCtD
Adenosine—ADK—Metabolism—NDUFA12—bone cancer	0.00366	0.00863	CbGpPWpGaD
Adenosine—Mediastinal disorder—Cisplatin—bone cancer	0.00356	0.00644	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—MDM2—bone cancer	0.00355	0.00838	CbGpPWpGaD
Adenosine—Arrhythmia—Cisplatin—bone cancer	0.00353	0.00638	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—TUBB4B—bone cancer	0.00347	0.00818	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—GRM4—bone cancer	0.00338	0.00797	CbGpPWpGaD
Adenosine—Cytarabine—CYP3A4—bone cancer	0.00335	0.147	CrCbGaD
Adenosine—ADA—C-MYB transcription factor network—PTGS2—bone cancer	0.00326	0.00769	CbGpPWpGaD
Adenosine—Vision blurred—Cisplatin—bone cancer	0.00324	0.00586	CcSEcCtD
Adenosine—Tremor—Cisplatin—bone cancer	0.00322	0.00583	CcSEcCtD
Adenosine—Cerebrovascular accident—Methotrexate—bone cancer	0.0032	0.00578	CcSEcCtD
Adenosine—ADK—Metabolism—NT5C3A—bone cancer	0.00303	0.00715	CbGpPWpGaD
Adenosine—Cardiac failure—Epirubicin—bone cancer	0.00301	0.00543	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—GNA11—bone cancer	0.003	0.00709	CbGpPWpGaD
Adenosine—Cerebrovascular accident—Epirubicin—bone cancer	0.00299	0.00541	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—TUBB2A—bone cancer	0.00299	0.00706	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—EZH2—bone cancer	0.00299	0.00706	CbGpPWpGaD
Adenosine—Convulsion—Cisplatin—bone cancer	0.00298	0.00539	CcSEcCtD
Adenosine—Mood swings—Methotrexate—bone cancer	0.00297	0.00537	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—GRM1—bone cancer	0.00293	0.00691	CbGpPWpGaD
Adenosine—Anxiety—Cisplatin—bone cancer	0.00292	0.00527	CcSEcCtD
Adenosine—Discomfort—Cisplatin—bone cancer	0.00289	0.00523	CcSEcCtD
Adenosine—Affect lability—Epirubicin—bone cancer	0.00289	0.00522	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—GRM4—bone cancer	0.00287	0.00678	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—PTGS2—bone cancer	0.00285	0.00673	CbGpPWpGaD
Adenosine—Anaphylactic shock—Cisplatin—bone cancer	0.00281	0.00507	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—bone cancer	0.00279	0.00504	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—bone cancer	0.00278	0.00503	CcSEcCtD
Adenosine—Mood swings—Epirubicin—bone cancer	0.00278	0.00502	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—bone cancer	0.00277	0.00501	CcSEcCtD
Adenosine—Tachycardia—Cisplatin—bone cancer	0.00274	0.00495	CcSEcCtD
Adenosine—Hyperhidrosis—Cisplatin—bone cancer	0.00271	0.00491	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—bone cancer	0.00267	0.00483	CcSEcCtD
Adenosine—Hypotension—Cisplatin—bone cancer	0.00262	0.00474	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—bone cancer	0.0026	0.00469	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—bone cancer	0.00258	0.00466	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—bone cancer	0.00257	0.00465	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00256	0.00462	CcSEcCtD
Adenosine—Paraesthesia—Cisplatin—bone cancer	0.00252	0.00456	CcSEcCtD
Adenosine—Dyspnoea—Cisplatin—bone cancer	0.0025	0.00452	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—GRM1—bone cancer	0.00249	0.00588	CbGpPWpGaD
Adenosine—ADA—Metabolism—NDUFA12—bone cancer	0.00249	0.00586	CbGpPWpGaD
Adenosine—Drowsiness—Methotrexate—bone cancer	0.00242	0.00437	CcSEcCtD
Adenosine—Pain—Cisplatin—bone cancer	0.0024	0.00434	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—bone cancer	0.00234	0.00423	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—GNA11—bone cancer	0.00232	0.00547	CbGpPWpGaD
Adenosine—Sweating—Methotrexate—bone cancer	0.00232	0.00419	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—EZH2—bone cancer	0.00231	0.00545	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—CDK4—bone cancer	0.00227	0.00536	CbGpPWpGaD
Adenosine—Drowsiness—Epirubicin—bone cancer	0.00226	0.00409	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—GRM4—bone cancer	0.00222	0.00523	CbGpPWpGaD
Adenosine—Sweating—Epirubicin—bone cancer	0.00217	0.00392	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—bone cancer	0.00217	0.00392	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—bone cancer	0.00211	0.00499	CbGpPWpGaD
Adenosine—Drowsiness—Doxorubicin—bone cancer	0.00209	0.00378	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—EIF2S1—bone cancer	0.00209	0.00492	CbGpPWpGaD
Adenosine—Hypersensitivity—Cisplatin—bone cancer	0.00207	0.00374	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—bone cancer	0.00207	0.00373	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—SMO—bone cancer	0.00206	0.00487	CbGpPWpGaD
Adenosine—ADA—Metabolism—NT5C3A—bone cancer	0.00206	0.00486	CbGpPWpGaD
Adenosine—Tinnitus—Methotrexate—bone cancer	0.00202	0.00365	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—bone cancer	0.00202	0.00365	CcSEcCtD
Adenosine—Asthenia—Cisplatin—bone cancer	0.00201	0.00364	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—bone cancer	0.00201	0.00364	CcSEcCtD
Adenosine—Sweating—Doxorubicin—bone cancer	0.00201	0.00362	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—bone cancer	0.00195	0.00353	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—GRM1—bone cancer	0.00192	0.00454	CbGpPWpGaD
Adenosine—Bradycardia—Doxorubicin—bone cancer	0.00191	0.00345	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—RGS1—bone cancer	0.00191	0.0045	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—GRM4—bone cancer	0.00191	0.0045	CbGpPWpGaD
Adenosine—Tinnitus—Epirubicin—bone cancer	0.00189	0.00342	CcSEcCtD
Adenosine—Flushing—Epirubicin—bone cancer	0.00188	0.0034	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—bone cancer	0.00188	0.0034	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—bone cancer	0.00187	0.00338	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—bone cancer	0.00185	0.00334	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—bone cancer	0.00183	0.00331	CcSEcCtD
Adenosine—Back pain—Methotrexate—bone cancer	0.00183	0.0033	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—bone cancer	0.00181	0.00328	CcSEcCtD
Adenosine—Vomiting—Cisplatin—bone cancer	0.00179	0.00323	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—bone cancer	0.00178	0.00322	CcSEcCtD
Adenosine—Rash—Cisplatin—bone cancer	0.00177	0.0032	CcSEcCtD
Adenosine—Dermatitis—Cisplatin—bone cancer	0.00177	0.0032	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—SMO—bone cancer	0.00176	0.00414	CbGpPWpGaD
Adenosine—Tinnitus—Doxorubicin—bone cancer	0.00175	0.00316	CcSEcCtD
Adenosine—Flushing—Doxorubicin—bone cancer	0.00174	0.00315	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—bone cancer	0.00174	0.00315	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—GRM4—bone cancer	0.00173	0.00409	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RGS1—bone cancer	0.00173	0.00409	CbGpPWpGaD
Adenosine—Tension—Epirubicin—bone cancer	0.00173	0.00313	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—bone cancer	0.00173	0.00313	CcSEcCtD
Adenosine—Nervousness—Epirubicin—bone cancer	0.00172	0.0031	CcSEcCtD
Adenosine—Back pain—Epirubicin—bone cancer	0.00171	0.00309	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—bone cancer	0.00169	0.00306	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—CDK4—bone cancer	0.00169	0.00398	CbGpPWpGaD
Adenosine—Arrhythmia—Doxorubicin—bone cancer	0.00168	0.00303	CcSEcCtD
Adenosine—Nausea—Cisplatin—bone cancer	0.00167	0.00301	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—bone cancer	0.00166	0.00301	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—GRM1—bone cancer	0.00166	0.00391	CbGpPWpGaD
Adenosine—Cough—Methotrexate—bone cancer	0.00165	0.00298	CcSEcCtD
Adenosine—Convulsion—Methotrexate—bone cancer	0.00164	0.00296	CcSEcCtD
Adenosine—ADORA2A—Signaling by NGF—ATF1—bone cancer	0.00163	0.00384	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—GRM4—bone cancer	0.00162	0.00383	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—RGS1—bone cancer	0.00162	0.00383	CbGpPWpGaD
Adenosine—Agitation—Epirubicin—bone cancer	0.00162	0.00293	CcSEcCtD
Adenosine—Chest pain—Methotrexate—bone cancer	0.00161	0.0029	CcSEcCtD
Adenosine—Tension—Doxorubicin—bone cancer	0.0016	0.0029	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—bone cancer	0.0016	0.00289	CcSEcCtD
Adenosine—Discomfort—Methotrexate—bone cancer	0.00159	0.00287	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—bone cancer	0.00159	0.00287	CcSEcCtD
Adenosine—Syncope—Epirubicin—bone cancer	0.00158	0.00286	CcSEcCtD
Adenosine—Back pain—Doxorubicin—bone cancer	0.00158	0.00286	CcSEcCtD
Adenosine—Palpitations—Epirubicin—bone cancer	0.00156	0.00282	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—bone cancer	0.00155	0.00281	CcSEcCtD
Adenosine—Cough—Epirubicin—bone cancer	0.00154	0.00279	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—bone cancer	0.00154	0.00278	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—bone cancer	0.00154	0.00278	CcSEcCtD
Adenosine—Convulsion—Epirubicin—bone cancer	0.00153	0.00277	CcSEcCtD
Adenosine—Hypertension—Epirubicin—bone cancer	0.00153	0.00276	CcSEcCtD
Adenosine—Chest pain—Epirubicin—bone cancer	0.0015	0.00272	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—GRM1—bone cancer	0.0015	0.00355	CbGpPWpGaD
Adenosine—Agitation—Doxorubicin—bone cancer	0.0015	0.00271	CcSEcCtD
Adenosine—Anxiety—Epirubicin—bone cancer	0.0015	0.00271	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—bone cancer	0.00149	0.00269	CcSEcCtD
Adenosine—Discomfort—Epirubicin—bone cancer	0.00149	0.00269	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—GRM4—bone cancer	0.00147	0.00348	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RGS1—bone cancer	0.00147	0.00348	CbGpPWpGaD
Adenosine—Dry mouth—Epirubicin—bone cancer	0.00147	0.00266	CcSEcCtD
Adenosine—Syncope—Doxorubicin—bone cancer	0.00147	0.00265	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—JUN—bone cancer	0.00146	0.00345	CbGpPWpGaD
Adenosine—Palpitations—Doxorubicin—bone cancer	0.00144	0.00261	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—bone cancer	0.00144	0.00261	CcSEcCtD
Adenosine—Hypotension—Methotrexate—bone cancer	0.00144	0.0026	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—bone cancer	0.00144	0.0026	CcSEcCtD
Adenosine—Cough—Doxorubicin—bone cancer	0.00143	0.00258	CcSEcCtD
Adenosine—Shock—Epirubicin—bone cancer	0.00142	0.00256	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—bone cancer	0.00142	0.00256	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—bone cancer	0.00141	0.00255	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—GRM1—bone cancer	0.00141	0.00332	CbGpPWpGaD
Adenosine—Tachycardia—Epirubicin—bone cancer	0.00141	0.00254	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.0014	0.00254	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—bone cancer	0.00139	0.00252	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—bone cancer	0.00139	0.00252	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—bone cancer	0.00139	0.00251	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—bone cancer	0.00138	0.0025	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—bone cancer	0.00137	0.00249	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—bone cancer	0.00137	0.00248	CcSEcCtD
Adenosine—Somnolence—Methotrexate—bone cancer	0.00137	0.00248	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—bone cancer	0.00136	0.00246	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—SMO—bone cancer	0.00136	0.0032	CbGpPWpGaD
Adenosine—Hypotension—Epirubicin—bone cancer	0.00135	0.00243	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—bone cancer	0.00133	0.00241	CcSEcCtD
Adenosine—ADK—Metabolism—ENO2—bone cancer	0.00133	0.00313	CbGpPWpGaD
Adenosine—Pain—Methotrexate—bone cancer	0.00132	0.00238	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00131	0.00237	CcSEcCtD
Adenosine—Shock—Doxorubicin—bone cancer	0.00131	0.00237	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—CDK4—bone cancer	0.0013	0.00308	CbGpPWpGaD
Adenosine—Tachycardia—Doxorubicin—bone cancer	0.0013	0.00235	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—bone cancer	0.00129	0.00234	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—bone cancer	0.00129	0.00233	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—bone cancer	0.00129	0.00232	CcSEcCtD
Adenosine—Somnolence—Epirubicin—bone cancer	0.00128	0.00232	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—GRM1—bone cancer	0.00128	0.00302	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—RGS1—bone cancer	0.00125	0.00296	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GRM4—bone cancer	0.00125	0.00296	CbGpPWpGaD
Adenosine—Hypotension—Doxorubicin—bone cancer	0.00125	0.00225	CcSEcCtD
Adenosine—Pain—Epirubicin—bone cancer	0.00123	0.00223	CcSEcCtD
Adenosine—ADK—Metabolism—DHFR—bone cancer	0.00123	0.00291	CbGpPWpGaD
Adenosine—Urticaria—Methotrexate—bone cancer	0.00122	0.00221	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00122	0.0022	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.0012	0.00284	CbGpPWpGaD
Adenosine—Paraesthesia—Doxorubicin—bone cancer	0.0012	0.00217	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—bone cancer	0.00119	0.00215	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—bone cancer	0.00119	0.00214	CcSEcCtD
Adenosine—ADK—Metabolism—GNA11—bone cancer	0.00115	0.00272	CbGpPWpGaD
Adenosine—Urticaria—Epirubicin—bone cancer	0.00115	0.00207	CcSEcCtD
Adenosine—Pain—Doxorubicin—bone cancer	0.00114	0.00206	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—RGS1—bone cancer	0.00114	0.00269	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GRM4—bone cancer	0.00114	0.00269	CbGpPWpGaD
Adenosine—Hypersensitivity—Methotrexate—bone cancer	0.00114	0.00205	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.00113	0.00267	CbGpPWpGaD
Adenosine—Asthenia—Methotrexate—bone cancer	0.00111	0.002	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—JUN—bone cancer	0.00109	0.00257	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GRM1—bone cancer	0.00109	0.00256	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—GNA11—bone cancer	0.00107	0.00252	CbGpPWpGaD
Adenosine—Hypersensitivity—Epirubicin—bone cancer	0.00106	0.00192	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—bone cancer	0.00106	0.00192	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—SMO—bone cancer	0.00106	0.0025	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP3A4—bone cancer	0.00104	0.00246	CbGpPWpGaD
Adenosine—Asthenia—Epirubicin—bone cancer	0.00103	0.00187	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—RGS1—bone cancer	0.00102	0.00242	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GRM4—bone cancer	0.00102	0.00242	CbGpPWpGaD
Adenosine—Dizziness—Methotrexate—bone cancer	0.00102	0.00184	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—GRM1—bone cancer	0.000987	0.00233	CbGpPWpGaD
Adenosine—Hypersensitivity—Doxorubicin—bone cancer	0.000983	0.00178	CcSEcCtD
Adenosine—Vomiting—Methotrexate—bone cancer	0.00098	0.00177	CcSEcCtD
Adenosine—Rash—Methotrexate—bone cancer	0.000971	0.00176	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—bone cancer	0.000971	0.00175	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—GNA11—bone cancer	0.000969	0.00229	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL3—bone cancer	0.000967	0.00228	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—bone cancer	0.000966	0.00228	CbGpPWpGaD
Adenosine—Headache—Methotrexate—bone cancer	0.000965	0.00174	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—bone cancer	0.000957	0.00173	CcSEcCtD
Adenosine—Dizziness—Epirubicin—bone cancer	0.000953	0.00172	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000948	0.00224	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KIT—bone cancer	0.000926	0.00218	CbGpPWpGaD
Adenosine—Vomiting—Epirubicin—bone cancer	0.000917	0.00166	CcSEcCtD
Adenosine—Nausea—Methotrexate—bone cancer	0.000915	0.00165	CcSEcCtD
Adenosine—Rash—Epirubicin—bone cancer	0.000909	0.00164	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—bone cancer	0.000908	0.00164	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—GNA11—bone cancer	0.000907	0.00214	CbGpPWpGaD
Adenosine—Headache—Epirubicin—bone cancer	0.000903	0.00163	CcSEcCtD
Adenosine—ADA—Metabolism—ENO2—bone cancer	0.000902	0.00213	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—SMO—bone cancer	0.000901	0.00212	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTP1—bone cancer	0.000892	0.00211	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GRM1—bone cancer	0.000888	0.0021	CbGpPWpGaD
Adenosine—Dizziness—Doxorubicin—bone cancer	0.000882	0.00159	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—IL3—bone cancer	0.000878	0.00207	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GRM4—bone cancer	0.000871	0.00205	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RGS1—bone cancer	0.000871	0.00205	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—BRAF—bone cancer	0.00087	0.00205	CbGpPWpGaD
Adenosine—Nausea—Epirubicin—bone cancer	0.000856	0.00155	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—MMP2—bone cancer	0.000854	0.00201	CbGpPWpGaD
Adenosine—Vomiting—Doxorubicin—bone cancer	0.000848	0.00153	CcSEcCtD
Adenosine—Rash—Doxorubicin—bone cancer	0.000841	0.00152	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—bone cancer	0.00084	0.00152	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—JUN—bone cancer	0.00084	0.00198	CbGpPWpGaD
Adenosine—ADA—Metabolism—DHFR—bone cancer	0.000837	0.00197	CbGpPWpGaD
Adenosine—Headache—Doxorubicin—bone cancer	0.000836	0.00151	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—GNA11—bone cancer	0.000824	0.00194	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL3—bone cancer	0.000822	0.00194	CbGpPWpGaD
Adenosine—Nausea—Doxorubicin—bone cancer	0.000792	0.00143	CcSEcCtD
Adenosine—ADA—Metabolism—GNA11—bone cancer	0.000782	0.00185	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GRM1—bone cancer	0.000755	0.00178	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL3—bone cancer	0.000747	0.00176	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MDM2—bone cancer	0.000729	0.00172	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—bone cancer	0.000718	0.00169	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP3A4—bone cancer	0.000709	0.00167	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GNA11—bone cancer	0.0007	0.00165	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—SMO—bone cancer	0.000695	0.00164	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GRM4—bone cancer	0.000673	0.00159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RGS1—bone cancer	0.000673	0.00159	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000648	0.00153	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GNA11—bone cancer	0.000636	0.0015	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL3—bone cancer	0.000635	0.0015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMO—bone cancer	0.000626	0.00148	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTP1—bone cancer	0.000607	0.00143	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GRM1—bone cancer	0.000583	0.00138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL3—bone cancer	0.000577	0.00136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNA11—bone cancer	0.000572	0.00135	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—bone cancer	0.000555	0.00131	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ATF1—bone cancer	0.000532	0.00126	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMO—bone cancer	0.000532	0.00126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL3—bone cancer	0.000519	0.00122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—bone cancer	0.000498	0.00118	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNA11—bone cancer	0.000487	0.00115	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—bone cancer	0.000462	0.00109	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ATF1—bone cancer	0.000452	0.00107	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFBR2—bone cancer	0.000444	0.00105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL3—bone cancer	0.000441	0.00104	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—bone cancer	0.000418	0.000985	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMO—bone cancer	0.000411	0.000969	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFBR2—bone cancer	0.000377	0.00089	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNA11—bone cancer	0.000376	0.000886	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—bone cancer	0.000355	0.000838	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ATF1—bone cancer	0.000349	0.000824	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL3—bone cancer	0.000341	0.000804	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—bone cancer	0.000314	0.000741	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KIT—bone cancer	0.000303	0.000714	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	0.000291	0.000687	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BRAF—bone cancer	0.000285	0.000671	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—bone cancer	0.000276	0.000651	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—bone cancer	0.000274	0.000647	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KIT—bone cancer	0.000257	0.000607	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BRAF—bone cancer	0.000242	0.000571	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MDM2—bone cancer	0.000238	0.000563	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—bone cancer	0.000235	0.000553	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—bone cancer	0.000207	0.000489	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MDM2—bone cancer	0.000203	0.000478	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—bone cancer	0.000202	0.000476	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KIT—bone cancer	0.000199	0.000469	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BRAF—bone cancer	0.000187	0.000441	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—bone cancer	0.000181	0.000427	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—bone cancer	0.000176	0.000416	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—bone cancer	0.000171	0.000405	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—bone cancer	0.000163	0.000384	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MDM2—bone cancer	0.000157	0.000369	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—bone cancer	0.000139	0.000327	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—bone cancer	0.000137	0.000323	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—bone cancer	0.000136	0.000321	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—bone cancer	0.000132	0.000312	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—bone cancer	0.000116	0.000274	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—bone cancer	0.000107	0.000252	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—bone cancer	8.98e-05	0.000212	CbGpPWpGaD
